Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP182078.RAN-52I00dLl2dISXKtxijNh9fNxbziUB0WUD9NCtcuVA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP182078.RAN-52I00dLl2dISXKtxijNh9fNxbziUB0WUD9NCtcuVA130_assertion type Assertion NP182078.RAN-52I00dLl2dISXKtxijNh9fNxbziUB0WUD9NCtcuVA130_head.
- NP182078.RAN-52I00dLl2dISXKtxijNh9fNxbziUB0WUD9NCtcuVA130_assertion description "[Data suggest that SPRY2, an inhibitor of ERK signaling, may be bypassed in melanoma cells either by down-regulation of its expression in WT BRAF cells, or by the presence of the BRAF mutation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP182078.RAN-52I00dLl2dISXKtxijNh9fNxbziUB0WUD9NCtcuVA130_provenance.
- NP182078.RAN-52I00dLl2dISXKtxijNh9fNxbziUB0WUD9NCtcuVA130_assertion evidence source_evidence_literature NP182078.RAN-52I00dLl2dISXKtxijNh9fNxbziUB0WUD9NCtcuVA130_provenance.
- NP182078.RAN-52I00dLl2dISXKtxijNh9fNxbziUB0WUD9NCtcuVA130_assertion SIO_000772 15313890 NP182078.RAN-52I00dLl2dISXKtxijNh9fNxbziUB0WUD9NCtcuVA130_provenance.
- NP182078.RAN-52I00dLl2dISXKtxijNh9fNxbziUB0WUD9NCtcuVA130_assertion wasDerivedFrom lhgdn-20090331 NP182078.RAN-52I00dLl2dISXKtxijNh9fNxbziUB0WUD9NCtcuVA130_provenance.
- NP182078.RAN-52I00dLl2dISXKtxijNh9fNxbziUB0WUD9NCtcuVA130_assertion wasGeneratedBy ECO_0000203 NP182078.RAN-52I00dLl2dISXKtxijNh9fNxbziUB0WUD9NCtcuVA130_provenance.